Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eledon Pharmaceuticals (ELDN) Depreciation & Amortization (CF) (2016 - 2020)

Eledon Pharmaceuticals filings provide 5 years of Depreciation & Amortization (CF) readings, the most recent being $4000.0 for Q4 2017.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 78.95% to $4000.0 in Q4 2017 year-over-year; TTM through Dec 2017 was $22000.0, a 81.67% decrease, with the full-year FY2020 number at $5000.0, down 44.44% from a year prior.
  • Depreciation & Amortization (CF) hit $4000.0 in Q4 2017 for Eledon Pharmaceuticals, up from $2000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $56000.0 in Q4 2015 to a low of -$4000.0 in Q3 2016.
  • Median Depreciation & Amortization (CF) over the past 5 years was $5000.0 (2014), compared with a mean of $16176.5.
  • Biggest five-year swings in Depreciation & Amortization (CF): surged 1020.0% in 2015 and later plummeted 112.5% in 2016.
  • Eledon Pharmaceuticals' Depreciation & Amortization (CF) stood at $3000.0 in 2013, then surged by 66.67% to $5000.0 in 2014, then surged by 1020.0% to $56000.0 in 2015, then crashed by 66.07% to $19000.0 in 2016, then tumbled by 78.95% to $4000.0 in 2017.
  • The last three reported values for Depreciation & Amortization (CF) were $4000.0 (Q4 2017), $2000.0 (Q3 2017), and $12000.0 (Q2 2017) per Business Quant data.